teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - mage-neoplasmer - antineoplastiske midler - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
metadon nordic drugs 120 mg
nordic drugs ab - metadonhydroklorid - mikstur, oppløsning - 120 mg
metadon nordic drugs 10 mg
nordic drugs ab - metadonhydroklorid - mikstur, oppløsning - 10 mg
metadon nordic drugs 15 mg
nordic drugs ab - metadonhydroklorid - mikstur, oppløsning - 15 mg
metadon nordic drugs 20 mg
nordic drugs ab - metadonhydroklorid - mikstur, oppløsning - 20 mg
metadon nordic drugs 25 mg
nordic drugs ab - metadonhydroklorid - mikstur, oppløsning - 25 mg
metadon nordic drugs 30 mg
nordic drugs ab - metadonhydroklorid - mikstur, oppløsning - 30 mg
metadon nordic drugs 35 mg
nordic drugs ab - metadonhydroklorid - mikstur, oppløsning - 35 mg
metadon nordic drugs 40 mg
nordic drugs ab - metadonhydroklorid - mikstur, oppløsning - 40 mg
metadon nordic drugs 45 mg
nordic drugs ab - metadonhydroklorid - mikstur, oppløsning - 45 mg